Smiths Medical 21-8065-24 - PORT INFUSION DUAL LUMEN TITANIUM PORT DETACHED 9.6FR POLYURETHANE CATHETER LO PROFILE

The Smiths Medical 21-8065-24 Port Infusion Dual Lumen Titanium Port is designed for reliable long-term vascular access in clinical infusion therapy. This low profile implanted port system features a dual lumen titanium port with a detached 9.6 Fr polyurethane catheter, supporting separate access pathways when multiple infusion therapies, blood draws, or treatment protocols are required.

Built for use in professional healthcare settings, this port infusion system is intended to help clinicians manage patients who need repeated or ongoing venous access while reducing the need for repeated peripheral needle placement. The titanium construction supports durability, while the low profile design helps improve patient comfort after implantation.

Key Benefits

• Dual lumen port design supports separate infusion pathways for complex therapy needs.
• Low profile titanium port helps reduce bulk under the skin and supports patient comfort.
• Detached 9.6 Fr polyurethane catheter allows clinician-controlled placement during implantation.
• Designed for long-term vascular access in oncology, infusion therapy, and specialty care settings.
• Titanium port body provides strength and durability for repeated access when used according to clinical protocol.
• Polyurethane catheter supports flexibility for vascular placement and ongoing therapy delivery.
• Suitable for facilities requiring dependable implanted port options for patients with recurring infusion needs.

Compatibility and Applications

The Smiths Medical 21-8065-24 dual lumen port infusion system is commonly used in hospital departments, infusion centers, oncology clinics, surgical settings, and specialty care programs where long-term vascular access is required. It may support therapies such as chemotherapy, medication infusion, hydration, blood sampling, and other physician-directed infusion procedures.

The dual lumen configuration is useful when patients require more than one access channel, helping clinicians manage multiple compatible therapies without relying solely on peripheral IV access. Compatibility should always be confirmed with facility protocols, prescribed therapy requirements, catheter care guidelines, and the manufacturers instructions for use.

Usage Guidelines

This implanted port system should be handled, implanted, accessed, flushed, and maintained only by qualified healthcare professionals trained in vascular access procedures. Proper aseptic technique must be followed throughout preparation, implantation, access, dressing, flushing, and maintenance.

Before use, inspect the product packaging and device components for integrity. Do not use the product if the package is opened, damaged, contaminated, or if sterility may have been compromised. Clinicians should confirm catheter size, port configuration, patient anatomy, intended therapy, and procedural requirements before implantation.

Access should be performed using appropriate non-coring port access needles and according to institutional policy. Flushing, locking, and maintenance schedules should follow physician orders, manufacturer recommendations, and current vascular access standards.

Certifications and Safety Standards

The Smiths Medical 21-8065-24 port infusion system is intended for regulated medical use and should be used in accordance with applicable healthcare facility policies, manufacturer instructions, and relevant clinical standards for implanted vascular access devices. Facilities should verify product documentation, labeling, sterility status, and regulatory compliance before clinical use.

As with all implanted vascular access devices, safe use depends on proper patient selection, sterile technique, correct implantation, appropriate access method, and ongoing monitoring for complications such as infection, occlusion, extravasation, catheter migration, thrombosis, or device malfunction.

Comparison with Competitors

Compared with standard single lumen implanted ports, the Smiths Medical 21-8065-24 dual lumen titanium port provides two separate access channels, which can be beneficial for patients requiring more complex treatment regimens. The low profile design may offer a more discreet and comfortable implanted option when compared with bulkier port configurations.

When compared with some plastic or non-titanium port bodies, titanium port construction is often selected for strength, durability, and long-term implanted use. The detached catheter format may also provide procedural flexibility for clinicians who prefer to position the catheter separately during placement. Product selection should be based on patient needs, therapy type, clinician preference, and institutional vascular access protocols.

Typical User Profile and Application Scenarios

This product is typically used by vascular access teams, interventional radiologists, surgeons, oncology clinicians, infusion nurses, and hospital-based procedural teams. It is suitable for patients who require repeated venous access over an extended treatment period and may benefit from an implanted port rather than frequent peripheral access.

Common application scenarios include oncology treatment programs, long-term medication infusion, recurring blood draws, hydration therapy, and specialty infusion protocols where dependable central venous access is clinically appropriate. The dual lumen design is especially useful when separate access channels are required for therapy management.

Best Practices for Use and Maintenance

Follow all manufacturer instructions and facility policies for implantation, access, flushing, locking, dressing care, and ongoing assessment. Use sterile technique during every access and maintenance procedure to reduce infection risk. Only compatible non-coring needles should be used when accessing the port.

Document port access, flushing, blood return, dressing changes, patient response, and any signs of complications according to facility standards. Monitor the port site regularly for redness, swelling, tenderness, drainage, leakage, pain, or signs of infection. Any resistance during flushing or infusion should be evaluated immediately and managed according to clinical protocol.

Store the product in a clean, dry, temperature-appropriate environment and keep it in its original packaging until ready for use. Do not resterilize or reuse single-use components unless explicitly permitted by the manufacturers instructions.

Regulatory and Safety Information

The Smiths Medical 21-8065-24 Port Infusion Dual Lumen Titanium Port with Detached 9.6 Fr Polyurethane Catheter is a medical device intended for professional healthcare use. It should not be used without proper clinical training, physician direction, and adherence to institutional vascular access procedures.

Patient assessment is essential before implantation. Clinicians should consider patient anatomy, therapy requirements, infection risk, coagulation status, allergy history, and overall treatment plan. All adverse events, suspected device issues, or performance concerns should be reported according to facility policy and applicable regulatory requirements.

How to Order

Select the Smiths Medical 21-8065-24 PORT INFUSION DUAL LUMEN TITANIUM PORT DETACHED 9.6FR POLYURETHANE CATHETER LO PROFILE and add it to your cart. Complete checkout with your preferred shipping and payment options. For bulk orders, quotes, or further assistance, contact CIA Medical customer service at (312)275-5850 or use the contact form on this page.